Guardant Health
GH
#1175
Rank
C$28.23 B
Marketcap
C$212.93
Share price
-2.47%
Change (1 day)
200.74%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of March 2026 : -C$0.26 Billion

According to Guardant Health 's latest financial reports the company has -C$0.26 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-C$0.14 Billion-32.13%
2024-12-31$-C$0.21 Billion-195.21%
2023-12-31$C$0.21 B157.74%
2022-12-31$C$81.66 M-90.07%
2021-12-31$C$0.82 B-52.44%
2020-12-31$C$1.72 B56.07%
2019-12-31$C$1.10 B54.88%
2018-12-31$C$0.71 B84.3%
2017-12-31$C$0.38 B262.28%
2016-12-31$C$0.10 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Neogen
NEOG
C$2.98 B-1,261.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
C$2.51 B-1,079.73%๐Ÿ‡บ๐Ÿ‡ธ USA